{
    "symbol": "NVCN",
    "quarter": 2,
    "year": 2022,
    "date": "2022-08-11 20:34:07",
    "content": " I can also tell you that, that's already also added in the US -- even before we did the COSIRA-II trial we had some patients in compassionate use and the physicians in Detroit and at the Cleveland clinic, who participated in compassionate use, saw the results of what reducer does in their own patient population and were extremely positive and excited about it, which is why they signed up to participate in the COSIRA-II and have been big support of us in getting the study going and in enrollment in that study."
}